Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial MomentumGlobeNewsWire • 05/20/26
Nyxoah SA (NYXH) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks TranscriptSeeking Alpha • 05/14/26
Nyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 05/05/26
Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating ResultsGlobeNewsWire • 03/19/26
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services ConferenceGlobeNewsWire • 03/11/26
Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026GlobeNewsWire • 03/05/26
Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle EastGlobeNewsWire • 02/18/26
Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide GrowthGlobeNewsWire • 01/21/26
Nyxoah SA (NYXH) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/20/26
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the NetherlandsGlobeNewsWire • 12/17/25
Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS RuleGlobeNewsWire • 11/26/25
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of GenioGlobeNewsWire • 11/13/25